July 2021 Simoa® Publications: Inflammation and Infectious Disease
Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
Nilles EJ, et al.
J Appl Lab Med. 2021
Infectious Disease- COVID 19
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Arunachalam PS, et al.
Nature. 2021
Infectious Disease- COVID 19
Pre-analytical sample handling effects on blood cytokine levels: quality control of a COVID-19 biobank
Verberk IM, et al.
Biomark Med. 2021
Infectious Disease- COVID 19
Granulocyte-Macrophage Colony Stimulating Factor in Single Blastocyst Conditioned Medium as a Biomarker for Predicting Implantation Outcome of Embryo
Chen P, et al.
Frontiers in immunology. 2021;12
Inflammation
Serum GFAP is a predictor of brain metastases in patients with metastatic breast cancer
Darlix A, et al.
International journal of cancer. 2021
Inflammation
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial
Stockfelt M, et al.
Arthritis research & therapy. 2021;23:189
Inflammation
IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases
De Ceuninck F, et al.
Drug Discovery Today. 2021
Inflammation
Prenatal immune stimulation alters the postnatal acute phase and metabolic responses to an endotoxin challenge in weaned beef heifers
Carroll JA, et al.
Transl Anim Sci. 2021;5:txab097
Inflammation
July 2021 Simoa® Publications in Other Therapeutic Areas
